Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that its Phase 2 clinical trial ...
Comprehensive, Compassionate Care for Patients and Families Facing ALS Cheryl Cook enjoyed a family vacation this summer in a ...
Century Health, a pioneer in applying AI to real-world data to accelerate research and advance therapeutics, and Memory Treatment Centers, a national leader in neurocognitive disease care, today ...
The new test can be used to identify pre-symptomatic patients with Parkinson's and can monitor progression of the disease. ATED Therapeutics Ltd. has been named the winner of the Fierce Life Sciences ...
Vancouver Sun on MSN
'You feel invisible': As its president, he led BCIT to excellence. Now he struggles to speak
Brian Gillespie is losing his ability to talk and walk five years after being diagnosed with a rare, incurable neurodegenerative condition. It's made him appreciate even more the importance of ...
In this interview, Kalpana Barnes highlights how new approach methodologies are addressing the gaps in drug discovery studies ...
Capital BioVentures (CBV), a leading biotech accelerator, dedicated to supporting the growth of early-stage life sciences companies, is proud to announce the launch of its newest offering, the ASCENT ...
New research commissioned by Challenge Works and undertaken by the Office of Health Economics (OHE) estimates that a ...
Explore trends before investing – request a sample report today! In 2024, CNS gene therapy development surged, supported by ...
The experimental therapy M102 slowed disease progression in preclinical experiments done in mouse and cell models of ALS, a ...
The 2025 Research Innovation Grants are supporting projects focused on biomarkers, risk factors, and treatments for ALS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback